Amyris files for bankruptcy, plans to sell consumer brands
Amyris, a biotech firm that produces sustainable ingredients for various industries, has filed for Chapter 11 bankruptcy protection in the U.S. court. The company said it intends to sell its consumer brands, such as Biossance and Pipette, to improve its…